A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa.

Bekker LG, Dintwe O, Fiore-Gartland A, Middelkoop K, Hutter J, Williams A, Randhawa AK, Ruhwald M, Kromann I, Andersen PL, DiazGranados CA, Rutkowski KT, Tait D, Miner MD, Andersen-Nissen E, De Rosa SC, Seaton KE, Tomaras GD, McElrath MJ, Ginsberg A, Kublin JG, HVTN 602/Aeras A-042 Protocol Team

Open source

DOI: 10.1016/j.eclinm.2020.100313
Published: 2020 Apr
Container: EClinicalMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2020.100313,
  title = {A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa.},
  author = {Bekker LG and Dintwe O and Fiore-Gartland A and Middelkoop K and Hutter J and Williams A and Randhawa AK and Ruhwald M and Kromann I and Andersen PL and DiazGranados CA and Rutkowski KT and Tait D and Miner MD and Andersen-Nissen E and De Rosa SC and Seaton KE and Tomaras GD and McElrath MJ and Ginsberg A and Kublin JG and HVTN 602/Aeras A-042 Protocol Team},
  year = {2020},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2020.100313},
  url = {https://doi.org/10.1016/j.eclinm.2020.100313}
}

RIS

TY  - JOUR
TI  - A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa.
AU  - Bekker LG
AU  - Dintwe O
AU  - Fiore-Gartland A
AU  - Middelkoop K
AU  - Hutter J
AU  - Williams A
AU  - Randhawa AK
AU  - Ruhwald M
AU  - Kromann I
AU  - Andersen PL
AU  - DiazGranados CA
AU  - Rutkowski KT
AU  - Tait D
AU  - Miner MD
AU  - Andersen-Nissen E
AU  - De Rosa SC
AU  - Seaton KE
AU  - Tomaras GD
AU  - McElrath MJ
AU  - Ginsberg A
AU  - Kublin JG
AU  - HVTN 602/Aeras A-042 Protocol Team
PY  - 2020
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2020.100313
UR  - https://doi.org/10.1016/j.eclinm.2020.100313
ER  -

APA

LG, B., O, D., A, F., K, M., J, H., A, W., AK, R., M, R., I, K., PL, A., CA, D., KT, R., D, T., MD, M., E, A., SC, D. R., KE, S., GD, T., MJ, M., A, G., JG, K., & Team, H. 6. A. P. (2020). A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2020.100313

Source records

pubmed · retrieved 2026-09-27T10:44:28.649Z